2016 International Congress

Monday, June 20, 2016

12:30pm-2:00pm

Detrusor overactivity is associated with frontal dysfunction in patients with Parkinson’s disease?

T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, Y. Watanabe, K. Hashimoto, T. Shingo, K. Kaga, C. Shibata-Yamaguchi, T. Yamanishi, R. Sakakibara, S. Kuwabara, K. Hirata (Tochigi, Japan)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Developing palliative care clinics for patients with advanced Parkinson’s disease: Practical approaches, challenges, and experiences

C.L. Dietiker, N.B. Galifianakis, M. Katz, S.L. Heath (San Francisco, CA, USA)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Development and external validation of a prognostic model of mortality in Parkinson’s disease

A.D. Macleod, I. Dalen, O.B. Tysnes, J.P. Larsen, C.E. Counsell (Aberdeen, United Kingdom)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Diagnostic value of cardiac 123I-MIBG SPECT and CT co-registration in PD and MSA-P

C. Kaindlstorfer, F. Krismer, A. Fanciulli, S. Eschlböck, M. Nocker, S. Bösch, K. Mair, C. Scherfler, A. Djamshidian-Tehrani, C. Uprimny, E. Donnemiller, I. Virgolini, K. Seppi, W. Poewe, G. Wenning (Innsbruck, Austria)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson’s disease diagnosis

M. Rossi, C. Terroba Chambi, A. Bril, P. Millar Vernetti, D. Cerquetti, A. Cammarota, M. Merello (Buenos Aires, Argentina)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome

A. Medina, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Direct assessment of psychosocial measures using eye tracking technology in advanced ALS – Can preserved autonomy and psychological wellbeing modify disease course?

K. Linse, W. Rüger, M. Joos, H. Schmitz-Peiffer, A. Storch, A. Hermann (Dresden, Germany)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry

L. Wang, N. Prinz, A. Marcus, K. Laubner, A. Zimmerman, S. Zlamal-Fortunat, M. Sharma, R. Holl (Tübingen, Germany)

Epidemiology and Quality of Life

12:30pm-2:00pm

Disease stage classification of the cerebellar variant of multiple system atrophy based on voxel-based morphometry

T. Taguchi, K. Nanri, Y. Ueta, H. Terashi, H. Aizawa (Tokyo, Japan)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Distribution of oscillatory activities in MRI confirmed subthalamic nucleus subregions

M. Beudel, A. Oswal, A. Jha, T. Foltynie, L. Zrinzo, M. Hariz, P. Limousin, S. Derrey, H. Akram, L. Vladimir, P. Brown (Groningen, Netherlands)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2